• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于去氧胆酸和叶酸修饰壳聚糖的两亲性聚合物胶束用于紫杉醇的递送。

Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel.

机构信息

Key Laboratory of Chemical Engineering Process & Technology for High-efficiency Conversion, College of Heilongjiang Province, School of Chemistry and Material Science, Heilongjiang University, Harbin 150080, China.

Key Laboratory of Photochemical Biomaterials and Energy Storage Materials, Heilongjiang Province, College of Chemistry & Chemical Engineering, Harbin Normal University, Harbin 150025, China.

出版信息

Int J Mol Sci. 2018 Oct 12;19(10):3132. doi: 10.3390/ijms19103132.

DOI:10.3390/ijms19103132
PMID:30322014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6213782/
Abstract

The present investigation aimed to develop a tumor-targeting drug delivery system for paclitaxel (PTX). The hydrophobic deoxycholic acid (DA) and active targeting ligand folic acid (FA) were used to modify water-soluble chitosan (CS). As an amphiphilic polymer, the conjugate FA-CS-DA was synthesized and characterized by Proton nuclear magnetic resonance (¹H-NMR) and Fourier-transform infrared spectroscopy (FTIR) analysis. The degree of substitutions of DA and FA were calculated as 15.8% and 8.0%, respectively. In aqueous medium, the conjugate could self-assemble into micelles with the critical micelle concentration of 6.6 × 10 mg/mL. Under a transmission electron microscope (TEM), the PTX-loaded micelles exhibited a spherical shape. The particle size determined by dynamic light scattering was 126 nm, and the zeta potential was +19.3 mV. The drug loading efficiency and entrapment efficiency were 9.1% and 81.2%, respectively. X-Ray Diffraction (XRD) analysis showed that the PTX was encapsulated in the micelles in a molecular or amorphous state. In vitro and in vivo antitumor evaluations demonstrated the excellent antitumor activity of PTX-loaded micelles. It was suggested that FA-CS-DA was a safe and effective carrier for the intravenous delivery of paclitaxel.

摘要

本研究旨在开发一种用于紫杉醇(PTX)的肿瘤靶向药物传递系统。疏水性去氧胆酸(DA)和活性靶向配体叶酸(FA)被用于修饰水溶性壳聚糖(CS)。作为一种两亲性聚合物,FA-CS-DA 缀合物通过质子核磁共振(¹H-NMR)和傅里叶变换红外光谱(FTIR)分析进行了合成和表征。DA 和 FA 的取代度分别计算为 15.8%和 8.0%。在水介质中,该缀合物可以自组装成胶束,临界胶束浓度为 6.6×10mg/mL。在透射电子显微镜(TEM)下,负载 PTX 的胶束呈现出球形。动态光散射法测定的粒径为 126nm,zeta 电位为+19.3mV。载药效率和包封效率分别为 9.1%和 81.2%。X 射线衍射(XRD)分析表明,PTX 以分子或无定形状态包封在胶束中。体外和体内抗肿瘤评价表明,负载 PTX 的胶束具有优异的抗肿瘤活性。因此,FA-CS-DA 是一种安全有效的紫杉醇静脉传递载体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/9847b1708d68/ijms-19-03132-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/3dba472e8848/ijms-19-03132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/b9fa010af2f4/ijms-19-03132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/f5e34fb420c0/ijms-19-03132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/f667f1e1762e/ijms-19-03132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/20526faebe12/ijms-19-03132-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/e351e3ddca7b/ijms-19-03132-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/b3904e3f066d/ijms-19-03132-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/9847b1708d68/ijms-19-03132-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/3dba472e8848/ijms-19-03132-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/b9fa010af2f4/ijms-19-03132-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/f5e34fb420c0/ijms-19-03132-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/f667f1e1762e/ijms-19-03132-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/20526faebe12/ijms-19-03132-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/e351e3ddca7b/ijms-19-03132-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/b3904e3f066d/ijms-19-03132-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c690/6213782/9847b1708d68/ijms-19-03132-g008.jpg

相似文献

1
Amphiphilic Polymeric Micelles Based on Deoxycholic Acid and Folic Acid Modified Chitosan for the Delivery of Paclitaxel.基于去氧胆酸和叶酸修饰壳聚糖的两亲性聚合物胶束用于紫杉醇的递送。
Int J Mol Sci. 2018 Oct 12;19(10):3132. doi: 10.3390/ijms19103132.
2
Tissue distribution and pharmacokinetics evaluation of DOMC-FA micelles for intravenous delivery of PTX.DOMC-FA 胶束静脉给药紫杉醇的组织分布和药代动力学评价。
J Drug Target. 2013 Feb;21(2):137-45. doi: 10.3109/1061186X.2012.731067. Epub 2012 Oct 9.
3
Polymeric Micelles Based on Modified Glycol Chitosan for Paclitaxel Delivery: Preparation, Characterization and Evaluation.基于改性壳聚糖的聚乙二醇胶束用于紫杉醇传递:制备、表征和评价。
Int J Mol Sci. 2018 May 23;19(6):1550. doi: 10.3390/ijms19061550.
4
Tumor-targeting micelles based on folic acid and α-tocopherol succinate conjugated hyaluronic acid for paclitaxel delivery.基于叶酸和 α-生育酚琥珀酸酯接枝透明质酸的肿瘤靶向胶束用于紫杉醇递送。
Colloids Surf B Biointerfaces. 2019 May 1;177:11-18. doi: 10.1016/j.colsurfb.2019.01.044. Epub 2019 Jan 23.
5
α-Tocopherol succinate-modified chitosan as a micellar delivery system for paclitaxel: preparation, characterization and in vitro/in vivo evaluations.α-生育酚琥珀酸酯修饰壳聚糖作为紫杉醇的胶束递送系统:制备、表征及体内外评价。
Int J Pharm. 2012 Feb 28;423(2):480-8. doi: 10.1016/j.ijpharm.2011.12.004. Epub 2011 Dec 13.
6
Development and in vitro/in vivo evaluation of a novel targeted polymeric micelle for delivery of paclitaxel.一种用于紫杉醇递送的新型靶向聚合物胶束的研发及体外/体内评价
Int J Biol Macromol. 2015 Sep;80:29-40. doi: 10.1016/j.ijbiomac.2015.05.062. Epub 2015 Jun 18.
7
In vitro evaluation on novel modified chitosan for targeted antitumor drug delivery.新型改性壳聚糖靶向抗肿瘤药物传递的体外评价。
Carbohydr Polym. 2013 Jan 30;92(1):545-54. doi: 10.1016/j.carbpol.2012.08.112. Epub 2012 Sep 6.
8
A novel preparation method of paclitaxcel-loaded folate-modified chitosan microparticles and in vitro evaluation.一种载有紫杉醇的叶酸修饰壳聚糖微粒的新型制备方法及体外评价
J Biomater Sci Polym Ed. 2016;27(3):276-89. doi: 10.1080/09205063.2015.1121366. Epub 2016 Jan 1.
9
In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle.载紫杉醇靶向壳聚糖基聚合物胶束的体内药代动力学、生物分布及抑瘤作用。
Drug Deliv. 2016 Jun;23(5):1707-17. doi: 10.3109/10717544.2014.954281. Epub 2014 Sep 4.
10
Novel amphiphilic folic acid-cholesterol-chitosan micelles for paclitaxel delivery.用于紫杉醇递送的新型两亲性叶酸-胆固醇-壳聚糖胶束
Oncotarget. 2017 Jan 10;8(2):3315-3326. doi: 10.18632/oncotarget.13757.

引用本文的文献

1
The Co-Delivery of Natural Products and Small RNAs for Cancer Therapy: A Review.用于癌症治疗的天然产物与小RNA的联合递送:综述
Molecules. 2025 Mar 27;30(7):1495. doi: 10.3390/molecules30071495.
2
Recent advances in polymeric nanoparticles for the treatment of hepatic diseases.用于治疗肝脏疾病的聚合物纳米颗粒的最新进展。
Front Pharmacol. 2025 Jan 24;16:1528752. doi: 10.3389/fphar.2025.1528752. eCollection 2025.
3
Enhancing Aqueous Solubility and Anticancer Efficacy of Oligochitosan-Folate-Cisplatin Conjugates through Oleic Acid Grafting for Targeted Nanomedicine Development.

本文引用的文献

1
Polymeric Micelles Based on Modified Glycol Chitosan for Paclitaxel Delivery: Preparation, Characterization and Evaluation.基于改性壳聚糖的聚乙二醇胶束用于紫杉醇传递:制备、表征和评价。
Int J Mol Sci. 2018 May 23;19(6):1550. doi: 10.3390/ijms19061550.
2
Copper-Free 'Click' Chemistry-Based Synthesis and Characterization of Carbonic Anhydrase-IX Anchored Albumin-Paclitaxel Nanoparticles for Targeting Tumor Hypoxia.基于无铜“点击”化学的碳酸酐酶-IX 锚定白蛋白-紫杉醇纳米粒子的合成与表征及其用于靶向肿瘤缺氧。
Int J Mol Sci. 2018 Mar 13;19(3):838. doi: 10.3390/ijms19030838.
3
Positively charged gold nanoparticles capped with folate quaternary chitosan: Synthesis, cytotoxicity, and uptake by cancer cells.
通过油酸接枝提高寡聚壳聚糖-叶酸-顺铂缀合物的水溶性和抗癌疗效以用于靶向纳米药物开发
ACS Omega. 2025 Jan 17;10(3):2428-2441. doi: 10.1021/acsomega.4c03529. eCollection 2025 Jan 28.
4
Preparation, Characterization, and Antioxidant Properties of Self-Assembled Nanomicelles of Curcumin-Loaded Amphiphilic Modified Chitosan.载姜黄素两亲改性壳聚糖自组装纳米胶束的制备、表征及抗氧化性能
Molecules. 2024 Jun 6;29(11):2693. doi: 10.3390/molecules29112693.
5
Exploiting Apical Sodium-Dependent Bile Acid Transporter (ASBT)-Mediated Endocytosis with Multi-Functional Deoxycholic Acid Grafted Alginate Amide Nanoparticles as an Oral Insulin Delivery System.利用多官能基去氧胆酸接枝海藻酸钠酰胺纳米粒经顶端钠依赖性胆酸转运蛋白(ASBT)介导的内吞作用作为口服胰岛素递药系统。
Pharm Res. 2024 Feb;41(2):335-353. doi: 10.1007/s11095-023-03641-7. Epub 2023 Dec 19.
6
Potential Application of Self-Assembled Peptides and Proteins in Breast Cancer and Cervical Cancer.自组装肽和蛋白质在乳腺癌和宫颈癌中的潜在应用。
Int J Mol Sci. 2023 Dec 2;24(23):17056. doi: 10.3390/ijms242317056.
7
L-Cysteine-Modified Transfersomes for Enhanced Epidermal Delivery of Podophyllotoxin.L-半胱氨酸修饰的传递体增强鬼臼毒素经皮传递
Molecules. 2023 Jul 28;28(15):5712. doi: 10.3390/molecules28155712.
8
pH-Responsive Water-Soluble Chitosan Amphiphilic Core-Shell Nanoparticles: Radiation-Assisted Green Synthesis and Drug-Controlled Release Studies.pH响应型水溶性壳聚糖两亲性核壳纳米粒子:辐射辅助绿色合成及药物控释研究
Pharmaceutics. 2023 Mar 5;15(3):847. doi: 10.3390/pharmaceutics15030847.
9
Advanced Phytochemical-Based Nanocarrier Systems for the Treatment of Breast Cancer.用于治疗乳腺癌的先进植物化学基纳米载体系统
Cancers (Basel). 2023 Feb 6;15(4):1023. doi: 10.3390/cancers15041023.
10
Nano-Sized Fucoidan Interpolyelectrolyte Complexes: Recent Advances in Design and Prospects for Biomedical Applications.纳米大小的褐藻糖胶聚电解质复合物:设计的最新进展及其在生物医学应用中的前景。
Int J Mol Sci. 2023 Jan 30;24(3):2615. doi: 10.3390/ijms24032615.
叶酸季铵盐壳聚糖修饰的正电荷金纳米粒子的合成、细胞毒性及癌细胞摄取。
Carbohydr Polym. 2018 Mar 1;183:140-150. doi: 10.1016/j.carbpol.2017.11.096. Epub 2017 Dec 8.
4
Polymeric bile acid sequestrants: Review of design, in vitro binding activities, and hypocholesterolemic effects.聚合型胆汁酸螯合剂:设计、体外结合活性及降胆固醇作用综述
Eur J Med Chem. 2018 Jan 20;144:300-317. doi: 10.1016/j.ejmech.2017.12.015. Epub 2017 Dec 6.
5
N-mercapto acetyl-N'-octyl-O, N″-glycol chitosan as an efficiency oral delivery system of paclitaxel.N-巯基乙酰-N′-辛基-O,N″-乙二醇壳聚糖作为紫杉醇的高效口服给药系统。
Carbohydr Polym. 2018 Feb 1;181:477-488. doi: 10.1016/j.carbpol.2017.10.066. Epub 2017 Oct 23.
6
A novel controlled drug delivery system based on alginate hydrogel/chitosan micelle composites.基于海藻酸钠水凝胶/壳聚糖胶束复合材料的新型控释给药系统。
Int J Biol Macromol. 2018 Feb;107(Pt A):855-864. doi: 10.1016/j.ijbiomac.2017.09.065. Epub 2017 Sep 19.
7
Chitosan as biomaterial in drug delivery and tissue engineering.壳聚糖作为药物传递和组织工程中的生物材料。
Int J Biol Macromol. 2018 Apr 15;110:97-109. doi: 10.1016/j.ijbiomac.2017.08.140. Epub 2017 Sep 1.
8
The battle of "nano" paclitaxel.紫杉醇纳米制剂的较量
Adv Drug Deliv Rev. 2017 Dec 1;122:20-30. doi: 10.1016/j.addr.2017.02.003. Epub 2017 Feb 28.
9
Development of drug delivery systems for taxanes using ionic gelation of carboxyacyl derivatives of chitosan.采用壳聚糖羧基酰衍生物的离子凝胶法开发紫杉醇给药系统。
Carbohydr Polym. 2017 Apr 15;162:49-55. doi: 10.1016/j.carbpol.2017.01.025. Epub 2017 Jan 6.
10
Trimethyl chitosan based conjugates for oral and intravenous delivery of paclitaxel.基于三甲基壳聚糖的缀合物用于紫杉醇的口服和静脉给药
Acta Biomater. 2017 Apr 15;53:355-366. doi: 10.1016/j.actbio.2017.02.012. Epub 2017 Feb 9.